Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
06/2005
06/07/2005US6902912 Fermentation via yeasts under aerobic conditions, then extraction
06/07/2005US6902909 Using leukemia cells as bioreactor for production of heterologous protein; gene therapy
06/07/2005US6902908 Polypeptides, fusion proteins; includes production and use recombinant expression constructs having regulated promoter; mitochondria
06/07/2005US6902885 For detecting viral and cellular polypeptide interactions
06/07/2005US6902734 Also an IL-12 anti-idiotype antibody to the antibody
06/07/2005CA2197651C Or-1 on orphan receptor belonging to the nuclear receptor family
06/07/2005CA2153135C Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains and compositions containing them
06/02/2005WO2005049852A2 Methods and compositions for inducing apoptosis
06/02/2005WO2005049847A1 Fusion proteins and methods of cleavage of such proteins
06/02/2005WO2005049823A1 Secretory protein production system
06/02/2005WO2005049807A1 Modification of protein glycosylation in methylotrophic yeast
06/02/2005WO2005049795A2 Mammalian cell lines for detecting, monitoring, and optimizing oligonucleotide-mediated chromosomal sequence alteration
06/02/2005WO2005049654A1 ANTI-Kank MONOCLONAL ANTIBODY
06/02/2005WO2005035749A3 Animal product free media and processes for obtaining a botulinum toxin
06/02/2005WO2005025497A3 Hpv cd8+ t-cell epitopes
06/02/2005WO2005024044A3 Method for the production of fusion proteins in transgenic mammal milk
06/02/2005WO2005005616A3 Compositions and methods for stable isotope labelling of biological compounds
06/02/2005WO2005001099A8 Protein expression system
06/02/2005WO2004093797A3 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots
06/02/2005WO2004087058A3 Targeted mhc class i alpha3 vaccine delivery systems
06/02/2005WO2004071414A3 Therapeutic anti-hcv (al9) compounds
06/02/2005WO2003090514A3 Adipocyte complement related protein zacrp14
06/02/2005WO2003087375A8 Cartilage differentiation regulating gene
06/02/2005US20050119465 Glycosylated follicle stimulating hormone for use as therapeutic tool in treatment of reproductive disorders
06/02/2005US20050119463 Antibody recognizing proliferative human liver cells proliferative human liver cells and functional human liver cells
06/02/2005US20050119462 Expression vectors and promoters for heterologous gene expression
06/02/2005US20050119458 Transport protein for use in identifying modulator for prevention and treatment of cell proliferative, skin and psychological disorders; anticonvulsants; insecticides; pesticides; anthelmintics
06/02/2005US20050119172 Purity, genetic engineered human serum albumin for Factor viii
06/02/2005US20050119171 Forsenic analysis; medical diagnosis; chromosome markers
06/02/2005US20050119165 Vascular endothelial growth factor dimers
06/02/2005US20050118684 Recombinant antihemophilic factor for use as tool in treatment hemophilia
06/02/2005US20050118683 Method for producing a polypeptide
06/02/2005US20050118682 Using transgenic animal to prepare osteoclastogenesis inhibitory factor (OCIF) for use in treatment of osteoporosis
06/02/2005US20050118673 Applying an enzyme for the selective removal of sub-unit parts of the polymer to at least one predetermined area of said polymeric substrate via a pipette with a nano-sized orifice
06/02/2005US20050118672 Using peptide: N-Glycosidase F (PNGase-F) to generate glycopeptide with uniform glycosylation patterns
06/02/2005US20050118668 Non-radioactive label fluorophore covalently bonded to a modified tyrosine residue
06/02/2005US20050118651 Immunoglobulin light chain comprising variable complementarity determining regions (CDRs) for use in diagnosis, prevention and treatment of alzheimer's disease; immunotherapy; immunodiagnostics
06/02/2005US20050118641 Quantitative analysis; for stabilization of insulin forms
06/02/2005US20050118638 Using thyrotrophin (TSH) receptor as diagnostic tool in detection of autoimmune diseases; competive binding assay
06/02/2005US20050118635 Using cytoskeletal membrane protein concentration as diagnostic indicator of cell proliferative disorders; antitumor agents
06/02/2005US20050118628 Synthesizing polynucleotide sequences based on model generated sequences; bioinformatics; directed evolution of proteins
06/02/2005US20050118617 Solid phase synthesis; microarrays
06/02/2005US20050118610 Nucleotide sequences coding hydrolase for generating protein hydrolysates useful as flavour improving agents; food processing
06/02/2005US20050118592 Using allelic variation aristaless homeobox gene (ARX) as diagnostic tool in detection of convulsive and learning disorders
06/02/2005US20050118586 Expression vector comprising nucleotide sequences coding heterologous polypeptide for use in forensic analysis as chromosome, tissue, cell and organelle specific markers
06/02/2005US20050118581 Novel brain expressed gene and protein associated with bipolar disorder
06/02/2005US20050118580 Nucleic acid which is stabilized against decomposition
06/02/2005US20050118575 Immune cell polypeptide for use in diagnosis and treatment of cell proliferative disorders
06/02/2005US20050118191 Optimization of gene sequences of chimeric virus-like particles for expression in insect cells
06/02/2005US20050118190 Staphylococcus antigen and vaccine
06/02/2005US20050118176 Inhibiting binding of interleukin-4 (IL-4) to an IL-4 Receptor; suppressing an IL-4-dependent immune or inflammatory response in a mammal
06/02/2005US20050118167 Parenteral pharmaceutical composition containing humanized monoclonal antibody fragment and stabilizing method thereof
06/02/2005US20050118165 useful for imaging such tumors; scintigraphic detection, diagnosis, prognosis, monitoring and therapy of Met-bearing tumors
06/02/2005US20050118161 Hevein-binding monoclonal antibodies
06/02/2005US20050118149 Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression
06/02/2005US20050118140 Madin Darby Canine Kidney cells are virally infected and cultured in suspension on an industrial scale to produce the active ingredient, and then mixed with a carrier or dilluent
06/02/2005DE4139840B4 Antigen-Zubereitung zum Nachweis von H. pylori Antigen preparation for the detection of H. pylori
06/02/2005CA2546840A1 Immunization against chlamydia infection
06/02/2005CA2546836A1 Immunization against chlamydia infection
06/02/2005CA2545693A1 Modification of protein glycosylation in methylotrophic yeast
06/02/2005CA2545024A1 Fusion proteins and methods of cleavage of such proteins
06/02/2005CA2486510A1 A process for creating a 3-dimensional configuration on a substrate
06/01/2005EP1536234A2 Soluble CTLA4 mutant molecules and uses thereof
06/01/2005EP1536020A1 Means and methods for optical determination of cAMP in vitro and in vivo
06/01/2005EP1536004A1 Method of promoting homologous recombination of somatic cells and method of constructing specific antibody
06/01/2005EP1535999A1 Milk-coagulating enzyme originating in bacterium and process for producing cheese using the same
06/01/2005EP1535929A2 Megakaryocyte stimulating factors
06/01/2005EP1535046A2 Screening antibodies using an optical fiber array device capable of simultaneously performing multiple functional assays
06/01/2005EP1535045A2 Screening compound libraries using an optical fiber array device capable of simultaneously performing multiple functional assays
06/01/2005EP1535044A2 Selecting therapeutic human monoclonal antibodies from disease-specific libraries
06/01/2005EP1534848A1 Method for extracting proteins
06/01/2005EP1534847A1 Retroviral vector and stable packaging cell lines
06/01/2005EP1534837A2 Apicomplexan pathways, inhibitiors, and drug delivery
06/01/2005EP1534835A1 Hansenula polymorpha yapsin deficient mutant strain and process for the preparation of recombinant proteins using the same
06/01/2005EP1534834A2 Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof
06/01/2005EP1534754A2 Bi-specific antigen-binding compositions and related methods
06/01/2005EP1534753A2 Antibody peg positional isomers, compositions comprising same, and use thereof
06/01/2005EP1534748A2 Fusion proteins and methods of producing same
06/01/2005EP1534736A2 Nogo receptor antagonists
06/01/2005EP1534729A2 Variants of nedd4l associated with hypertension and viral budding
06/01/2005EP1534658A2 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
06/01/2005EP1534341A1 Therapeutic system targeting pathogen proteases and uses thereof
06/01/2005EP1534332A2 Antibodies and uses thereof
06/01/2005EP1534331A2 Membrane associated tumor endothelium markers
06/01/2005EP1534324A2 Tumor specific oligosaccharide epitopes and use thereof
06/01/2005EP1534066A2 Alpha(1,3)-galactosyltransferase null cells, methods of selecting and alpha(1,3)-galactosyltransferase null swine produced therefrom
06/01/2005EP1483397A4 Oligomeric molecules and uses thereof
06/01/2005EP1319074B1 Process for producing peptides by using i in vitro /i transcription/translation system
06/01/2005EP1311162B1 Bacillus thurigiensis crystal protein hybrids
06/01/2005EP1169282B1 Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor
06/01/2005EP1042460B1 Brain or heart cyclic nucleotide gated ion channel compounds and uses thereof
06/01/2005EP0906433B1 Protein tyrosine phosphatases of hematopoietic cells
06/01/2005EP0804559B1 Enzyme for cleavage of the anchor region of surface proteins from gram positive bacteria
06/01/2005EP0656941B1 Methods for producing members of specific binding pairs
06/01/2005CN1622998A Fungus-origin lysyl oxidases
06/01/2005CN1622995A Receptor nucleic acids and polypeptides
06/01/2005CN1622958A Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
06/01/2005CN1622957A IFNAR2 mutants, their production and use
06/01/2005CN1622956A Cytotoxic cyplasin of the sea hare, aplysia punctata, cdna cloning and expression of bioreactive recombinants
06/01/2005CN1622760A A process for the extraction, purification and enzymatic modification of soy 7S globulin alpha' subunit for use as hypocholesterolemizing agent
1 ... 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 ... 1125